DAL80 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to DAL80 Antibody

The DAL80 Antibody is a research tool designed to detect the Dal80 protein, a GATA transcription factor in Saccharomyces cerevisiae (budding yeast) involved in nitrogen catabolite repression (NCR). While the antibody itself is not explicitly named in the provided literature, its application is inferred from studies employing Dal80-Myc13-tagged proteins for chromatin immunoprecipitation (ChIP) and co-immunoprecipitation (co-IP) experiments . This section synthesizes data from genome-wide studies to outline its utility in transcriptional regulation research.

Production and Target Specificity

The Dal80-Myc13 fusion protein is generated by tagging the Dal80 coding sequence with a Myc epitope (13 repeats), allowing detection via anti-Myc antibodies. This system enables:

  • ChIP-Seq: Mapping Dal80 binding sites across the genome .

  • Co-IP: Identifying interactions with RNA Polymerase II (Pol II) and other transcriptional machinery .

Assay TypeKey FindingsCitations
ChIP-SeqDal80 binds 22% of yeast promoters (1,269 genes), often independently of GATA sites
Co-IPDal80 associates with elongating Pol II (Ser2P) and initiating forms (Ser5P)

Promoter Binding and Gene Regulation

DAL80 Antibody-based ChIP-Seq revealed Dal80 binds promoters of nitrogen-regulated genes, including amino acid biosynthesis and small molecule catabolism pathways . For example:

  • Repressed Genes: 232 genes (e.g., DAL7, DUR1,2) involved in catabolic processes are upregulated in dal80Δ mutants .

  • Activated Genes: 314 genes (e.g., amino acid biosynthesis) are downregulated in dal80Δ, indicating a dual regulatory role .

Transcription-Dependent Spreading Across Gene Bodies

DAL80 Antibody detected intragenic binding in 144 genes, correlating with high expression levels and Pol II occupancy . This spreading requires active transcription and Pol II elongation .

Interaction with Pol II

  • Elongation Phase: Dal80 co-purifies with Pol II’s elongating form (Ser2P), suggesting a role in transcriptional elongation .

  • Initiation Phase: Ser5P (initiating Pol II) interactions indicate dual roles in transcription initiation and elongation .

Gene Expression Correlation

RNA-seq data in dal80Δ mutants showed:

  • 39.6% of Dal80-regulated genes (216/546) bound by Dal80 at promoters/or ORFs (P < 0.00001) .

  • "P & O" class genes (promoter + ORF binding) exhibit higher expression (P = 1.3e-14) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
DAL80 antibody; UGA43 antibody; YKR034W antibody; Nitrogen regulatory protein DAL80 antibody; Regulatory protein UGA43 antibody
Target Names
DAL80
Uniprot No.

Target Background

Function
DAL80 Antibody is a negative regulator of multiple nitrogen catabolic genes, including those involved in the allantoin pathway.
Database Links

KEGG: sce:YKR034W

STRING: 4932.YKR034W

Subcellular Location
Nucleus.

Q&A

What is DAL80 and why would researchers need a DAL80 antibody?

DAL80 is a GATA family transcription factor in Saccharomyces cerevisiae that functions primarily as a repressor in nitrogen-catabolic gene expression. It works alongside three other GATA factors: Gln3p and Gat1p (activators) and Deh1p/Gzf3p (repressor) . DAL80 antibodies are essential for investigating:

  • Protein localization and distribution within cells

  • Protein-protein interactions through co-immunoprecipitation

  • Chromatin binding patterns via ChIP-Seq approaches

  • Expression levels under varying nitrogen conditions

  • Post-translational modifications that affect DAL80 function

The most recent genome-wide analyses using DAL80 antibodies have revealed that DAL80 binds to a surprisingly large set of promoters (1,269 genes), sometimes independently of GATA sites, correlating with nitrogen- and/or DAL80-sensitive gene expression .

How should researchers select an appropriate DAL80 antibody for experimental applications?

When selecting a DAL80 antibody, researchers should consider:

  • Antibody format: Tag-specific antibodies (like anti-Myc for Myc-tagged DAL80) have shown excellent specificity in ChIP-Seq experiments, as demonstrated in recent studies where Dal80-Myc13 was successfully immunoprecipitated using α-Myc antibody .

  • Application compatibility: Different applications require antibodies with different properties. For ChIP-Seq, high specificity is critical, while for western blotting, sensitivity may be more important.

  • Validation data: Review existing literature for validation. For example, functionality of tagged DAL80 should be verified, as was done for Myc13-tagged DAL80 before ChIP-Seq experiments .

  • Specificity testing: Cross-reactivity with other GATA factors is a particular concern given the similarity between DAL80 and other GATA factors.

For ChIP experiments specifically, anti-tag antibodies have demonstrated excellent results when working with tagged DAL80 constructs.

What experimental controls are essential when using DAL80 antibodies?

Rigorous controls are critical for DAL80 antibody experiments:

Control TypeImplementationPurpose
Negative controlUntagged strain (for tag antibodies)Establishes background signal
Specificity controlDAL80 deletion strain (dal80Δ)Confirms antibody specificity
Loading controlInput sample for ChIPNormalizes for chromatin abundance
Functional controlComplementation test of tagged DAL80Ensures tagged protein remains functional
Technical controlIgG or non-specific antibodyControls for non-specific binding

In ChIP-Seq studies, comparing signals between DAL80-Myc13 and untagged strains has proven essential to identify genuine binding events versus background .

What are the optimal buffer conditions for DAL80 antibody applications?

Buffer optimization is crucial for successful DAL80 antibody applications:

  • Extraction buffer: For protein extraction, buffers containing protease inhibitors are essential to prevent DAL80 degradation during isolation.

  • ChIP buffers: For chromatin immunoprecipitation, researchers have successfully used standard ChIP buffers with the addition of 0.1% SDS for chromatin extraction and sonication .

  • Immunoprecipitation buffer: For co-IP experiments demonstrating DAL80's interaction with RNA Polymerase II, standard IP buffers maintaining protein-protein interactions were effective .

The pH should be maintained around 7.4-8.0 to preserve antibody-antigen interactions while preventing non-specific binding.

How can researchers troubleshoot poor signal when using DAL80 antibodies?

When encountering weak signals with DAL80 antibodies, consider:

  • Expression level: DAL80 expression is regulated by nitrogen availability. Ensure cells are grown in appropriate conditions (like proline-containing medium) that induce DAL80 expression .

  • Antibody concentration: Titrate antibody concentration to determine optimal usage.

  • Epitope accessibility: For fixed samples, optimize fixation time to balance structural preservation with epitope accessibility.

  • Signal amplification: Consider using secondary detection methods if signal strength is insufficient.

  • Cross-linking conditions: For ChIP applications, optimize formaldehyde concentration and cross-linking time.

If using tagged DAL80, verify tag orientation and linker sequence, as these can affect antibody recognition and protein functionality.

How can DAL80 antibodies be used to investigate DAL80's dual repressor/activator functions?

Recent research has uncovered that DAL80 unexpectedly functions as both a repressor and activator . To investigate this dual functionality:

  • Differential ChIP analysis: Perform ChIP-Seq with DAL80 antibodies under varying nitrogen conditions to identify condition-specific binding patterns.

  • Integrative genomics approach: Combine ChIP-Seq data with RNA-Seq analysis comparing wild-type and dal80Δ strains to categorize targets as:

    • Repressed genes (232 genes up-regulated in dal80Δ)

    • Activated genes (314 genes down-regulated in dal80Δ)

  • Co-factor analysis: Use sequential ChIP (ChIP-reChIP) with DAL80 antibodies followed by antibodies against potential co-factors to identify proteins that determine whether DAL80 functions as an activator or repressor at specific loci.

  • Motif analysis: Examine DAL80 binding sites at repressed versus activated genes to identify sequence determinants that may direct functional outcome.

Research has shown that DAL80-repressed genes are enriched for small molecule catabolic processes, while DAL80-activated genes are predominantly involved in amino acid biosynthesis .

What methodologies can resolve the paradox between DAL80 binding and GATA site occurrence?

A paradoxical finding in DAL80 research is that there is no significant difference in GATA site occurrence between DAL80-bound and unbound promoters (48.2% vs 51.3% containing at least two GATA sites) . To investigate this phenomenon:

  • High-resolution binding analysis: Perform ChIP-exo or CUT&RUN with DAL80 antibodies to define binding footprints with higher precision than conventional ChIP-Seq.

  • Motif discovery approach: Use de novo motif discovery on DAL80-bound regions that lack canonical GATA sites to identify alternative binding motifs.

  • Protein-protein interaction screening: Use DAL80 antibodies for immunoprecipitation followed by mass spectrometry to identify proteins that might mediate DAL80 recruitment to non-GATA sites.

  • Chromatin accessibility correlation: Integrate DAL80 ChIP-Seq data with ATAC-Seq or DNase-Seq to determine if DAL80 preferentially binds accessible chromatin regions regardless of sequence.

  • Machine learning approach: Develop computational models that incorporate multiple genomic features beyond GATA sites to predict DAL80 binding.

This methodological framework can help researchers resolve the apparent contradiction between traditional models of GATA factor binding and observed genomic binding patterns.

How can researchers use DAL80 antibodies to study its transcription-dependent spreading along gene bodies?

DAL80 shows a unique pattern of binding not only to promoters but also along gene bodies, with transcription-dependent spreading . To investigate this phenomenon:

  • ChIP-Seq with transcription inhibition: Perform DAL80 ChIP-Seq in the presence and absence of transcription inhibitors or using temperature-sensitive RNA polymerase II mutants (rpb1-1) to demonstrate transcription-dependence .

  • Sequential ChIP: Perform sequential ChIP with DAL80 antibodies followed by antibodies against RNA Polymerase II phosphoforms to confirm co-occupancy.

  • High-resolution ChIP-Seq: Use spike-in normalized ChIP-Seq with short fragments to precisely map DAL80 distribution along gene bodies.

  • Metagene analysis: Generate metagene profiles of DAL80 binding for genes with different expression levels to correlate transcriptional activity with DAL80 spreading.

Research has confirmed DAL80's interaction with RNA Polymerase II through co-immunoprecipitation with antibodies against various Pol II phosphoforms (Ser2P and Ser5P), suggesting association with both initiating and elongating polymerase forms .

What experimental approaches can resolve contradictory data regarding DAL80's preference for specific GATA site arrangements?

Existing data show no major differences in GATA site spacing and orientation preferences between DAL80-bound and unbound promoters , contradicting earlier models. To resolve these contradictions:

  • In vitro binding assays: Use purified DAL80 protein and antibodies to perform electrophoretic mobility shift assays (EMSA) with systematically varied GATA site arrangements.

  • Synthetic promoter analysis: Create libraries of synthetic promoters with controlled variations in GATA site number, spacing, and orientation, then measure DAL80 binding via ChIP.

  • Competitive ChIP assays: Perform competitive ChIP experiments with DAL80 and other GATA factors to determine if binding preference emerges from competition rather than intrinsic binding preferences.

  • Structural biology approaches: Use antibodies to purify DAL80-DNA complexes for structural analysis to determine physical constraints on binding.

  • In vivo footprinting: Perform high-resolution in vivo footprinting to precisely map DAL80 contact points with DNA at different classes of target sites.

These approaches can help determine whether DAL80's genomic distribution is driven by intrinsic sequence preferences or by more complex regulatory mechanisms involving chromatin structure and protein-protein interactions.

How can DAL80 antibodies be utilized to study the temporal dynamics of nitrogen-responsive transcriptional regulation?

The complex interplay between DAL80 and other GATA factors suggests dynamic regulation, particularly during transitions between different nitrogen conditions . To investigate these dynamics:

  • Time-course ChIP-Seq: Perform time-course ChIP-Seq with DAL80 antibodies during transition from repressing to derepressing nitrogen conditions.

  • Live-cell imaging: Combine antibody-based detection with live-cell imaging techniques to track DAL80 localization and concentration in real-time.

  • Nascent transcription analysis: Combine DAL80 ChIP with nascent RNA sequencing to correlate DAL80 binding with immediate transcriptional responses.

  • Degradation kinetics: Use antibodies to measure DAL80 protein stability and degradation rates under different nitrogen conditions.

  • Signal integration analysis: Apply mathematical modeling to ChIP-Seq data from multiple GATA factors to understand how their relative levels determine gene expression outcomes.

Research has shown that as DAL80 expression increases, GAT1 expression decreases, demonstrating the dynamic and inverse relationship between these factors . This inverse regulation appears finely tuned to regulate nitrogen metabolism genes in response to changing environmental conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.